Intrexon and Surterra Wellness partner in $100 million deal for cannabinoids fermentation
Intrexon and Surterra Wellness announced an exclusive global licensing agreement. The companies advance Surterra's cannabinoid production at a reliable, efficient, cost-effective, industrial scale utilizing Intrexon's proprietary yeast fermentation platform. June 18, 2019